Display Settings:

Format

Send to:

Choose Destination
    Nat Biotechnol. 2009 Jun;27(6):531-7.

    Wasting cash--the decline of the British biotech sector.

    Abstract

    Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.

    PMID:
    19513054
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk